Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)
Clinical trial NCT00704184 · COMPLETED
Trial details
- NCT number
- NCT00704184
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-25
- Primary completion
- 2008-12-12
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.